Statistics

Total Visits

Views
The adverse effect of high sokal risk for first line imatinib treated patients is overcome by a rapid rate of BCR-ABL decline measured as early as 1 month of treatment(legacy) 75
The adverse effect of high sokal risk for first line imatinib treated patients is overcome by a rapid rate of BCR-ABL decline measured as early as 1 month of treatment(legacy) 66

Total Visits per Month

October 2023 November 2023 December 2023 January 2024 February 2024 March 2024 April 2024
The adverse effect of high sokal risk for first line imatinib treated patients is overcome by a rapid rate of BCR-ABL decline measured as early as 1 month of treatment 0 3 3 1 0 0 1

File Downloads

Views

Top Country Views

Views
United States 48
China 23
France 11
Netherlands 8
Vietnam 5
Australia 4
Germany 1
United Kingdom 1
Sweden 1
Singapore 1

Top City Views

Views
Ashburn 17
Rotterdam 8
Beijing 6
Hanoi 5
Fairfield 4
Zhengzhou 4
Kaleen 3
Changchun 2
Qingping 2
Seattle 2